About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

133.32 -41.06 (-23.55%)
Official Closing Price Updated: 4:15 PM EDT, Aug 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Moderna's Comeback Is Finally Taking Shape -- and There May Be More Upside Ahead ↗
Breaking news: Moderna isn't just a "pandemic stock" after all. 
Via The Motley Fool
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Looking for the most active stocks in the S&P500 index on Thursday? ↗
Via Chartmill
Thursday's session: most active stocks ↗
Via Chartmill
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗
Via Chartmill
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗
Via Chartmill
Top S&P500 movers in Wednesday's pre-market session ↗
Via Chartmill
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Why Moderna (MRNA) Stock Is Trading Lower Today
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 20% in the morning session after investors took profits as the stock surged over 17... 
Via StockStory
Topics Artificial Intelligence
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
Moderna Doubles on Melanoma Vaccine Win, Treasury Steps In to Cap Long-End Yields ↗
Via Chartmill
News headline image
Why Moderna Stock Skyrocketed Today ↗
The biotech could be on the verge of setting a new standard of care for skin cancer. 
Via The Motley Fool
News headline image
Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma Data ↗
Today, Aug. 19, 2026, Moderna's personalized cancer vaccine met its late-stage goal, with the company and Merck planning an FDA submission. 
Via The Motley Fool
Topics Stocks
What's going on in today's after hours session ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Here are the top movers in Wednesday's session. ↗
Via Chartmill
What's going on in today's session: S&P500 most active stocks ↗
Via Chartmill
Which stocks are most active on Wednesday? ↗
Via Chartmill
News headline image
Pfizer Stock Rises Wednesday: What's Going On? ↗
Pfizer Inc (NYSE:PFE) shares are trading higher Wednesday, moving in sympathy with mRNA cancer vaccine-related companies after Merck & Co Inc (NYSE:MRK) and Moderna Inc (NASDAQ:MRNA) announced that... 
Via Benzinga
News headline image
Why Is Moderna (MRNA) Stock Rocketing Higher Today
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 144% in the afternoon session after its personalized mRNA cancer vaccine, develop... 
Via StockStory
News headline image
Broadcom Drags the Nasdaq While the Dow and S&P 500 Climb ↗
Most stocks rose Wednesday, but a few big tech names told a different story. Here's what split the market again. 
Via The Motley Fool
Topics Stocks
News headline image
Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors. ↗
The treatment combines an mRNA shot with Merck's Keytruda. 
Via The Motley Fool
What's going on in today's session: S&P500 movers ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Which S&P500 stocks are gapping on Wednesday? ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Moderna (MRNA): Buy, Sell, or Hold Post Q2 Earnings?
What a fantastic six months it’s been for Moderna. Shares of the company have skyrocketed 44.2%, hitting $63.36. This was partly due to its solid quarterly r... 
Via StockStory
News headline image
3 Unprofitable Stocks We Keep Off Our Radar
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.